store at low temperature
store at -80°C
Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 100,500 |
5 mg | 在庫あり | ¥ 226,500 |
10 mg | 在庫あり | ¥ 317,000 |
25 mg | 在庫あり | ¥ 454,500 |
50 mg | 在庫あり | ¥ 636,000 |
100 mg | 在庫あり | ¥ 856,000 |
説明 | Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC). |
分子量 | N/A |
CAS No. | 1228763-95-8 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Monalizumab 1228763-95-8 Cell Cycle/Checkpoint Immunology/Inflammation IFNAR Chk Inhibitor inhibitor inhibit